The health minister said the present research agenda for COVID-19 has been to provide an affordable vaccine as well as to ensure its equitable distribution.
Currently, three Indian pharma companies in partnership with foreign or domestic research institutes are expediting the trials of vaccine, the statement said.
The biggest benefit that India has is that it has a robust immunization program in place and it is also implementing the largest immunization program of the world, with nearly 27 million newborns targeted annually, the minister said.
"We have an established infrastructure for supply, storage and delivery of vaccines to the last mile under our Universal Immunization Program as part of which we are administering around 600 million doses to children every year.
"The strength of these experiences in the vaccination landscape, our best practices and the robustness of our health delivery system will be leveraged and augmented using a strong IT backbone to ensure that this humongous national mission of vaccinating the identified priority groups with COVID-19 vaccine is achieved in a timely manner.
"The Indian government will leverage an integrated IT platform e-Vin (electronic Vaccine Intelligent Network) for managing vaccine distribution," Vardhan said.
He re-affirmed the commitment of the Indian government and assured that it has accorded top-most priority to the research and manufacturing to ensure that the vaccine reaches the last person.
"The India story has always been very inspiring as we have made huge strides in improving the health of our people in the last two decades. And now, India's contribution will be critical to fighting COVID-19, especially when it comes to making vaccines at large scale for the whole world," the minister was quoted as saying in the statement.
Emphasizing India's role during the pandemic, Vardhan said, "The inclusiveness of India's response has led us to manage the pandemic currently. The COVID pandemic has created disruption in normal life but has also provided a steep learning curve for all of us to be more resilient and prepared for the future. These efforts have been a result of commitment from all stakeholders."
India has been following a pre-emptive, proactive, and graded response characterised by a "Whole of Society, Whole of Government" approach to manage the challenges posed by the global pandemic, he said.
Lauding the support of private sector in India's COVID-19 management, he stated that its innovation, ability and agility has supported the efforts to fight coronavirus in a big way.
"PPEs, N95 masks, oxygen, ventilators and diagnostic tests kits were developed at a jet pace to ensure self-sufficiency. Medical infrastructure saw an exponential growth, from having one lab in March, 2020 to around 2,000 laboratories as on date with nearly half of the labs from the private sector. The same is true for dedicated ICU facilities and isolation centers," he said.
"The pandemic has taught us that preparedness costs only a fraction of its impact, but returns on the investment are exponential," he said.
Vardhan said that due to the unprecedented challenges faced by the world on account of the pandemic, India is making use of Information Technology in virtually every aspect of COVID management.
AarogyaSetu app and ITIHAS, a cellular-based tracking technology has been used for surveillance and identification of potential clusters, RT-PCR app for testing, facility application for managing information on admitted patients and all have been integrated with a single COVID portal, he said.
"AarogyaSetu App is presently being used by more than 170 million Indians making it one of the most downloaded apps in the world. A web-based tele-consultation service has been initiated to enable non-COVID-19 healthcare services. So far, more than 0.60 million tele-consultations have been conducted and more people are getting on-board," he said.
The Union health minister spoke at length about India's preparedness to deal with pandemics and commitment to ensure affordable healthcare delivery to all.
"We rolled out a special economic and comprehensive package of 272 US Billion Dollars - equivalent to 10 per cent of India's GDP under Atmanirbhar Bharat Abhiyaan (Self Reliance India Programme) which includes a component of increasing investments in public health and health reforms to prepare India for future pandemics.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.